For decades, prostate cancer screening was a routine part of healthcare for men of a certain age. Over time, doctors began to realize that the PSA test wasn’t always a reliable indicator of cancer. The U.S. Preventive Services Task Force set out to determine whether the benefits of the PSA test could justify these risks. Some clinical research suggests strongly that more prostate cancer deaths could be averted if physicians used PSA thresholds that were lower than those widely used in the United States to diagnose prostate cancer. It may also prevent as many as three cases of prostate cancer that spread to other organs.

Source: Los Angeles Times April 12, 2017 00:04 UTC